HRSA Issues RFI on New 340B Rebate Model Pilot Program, Members Encouraged to Comment by April 20
What’s happening: The Health Resources and Services Administration (HRSA) has issued a request for information (RFI) on whether to implement a new 340B rebate model pilot program and how it might be designed. Comments were originally due by March 19, but HRSA is extending the deadline to April 20.
HHS Takes Initial Step Toward Restarting Review Process for 340B Rebate Model
What's happening: The Department of Health and Human Services (HHS) has taken a step toward restarting the administrative process for establishing a 340B rebate model, filing a notice with the Office of Management and Budget that it will look to publish an advance notice of proposed rulemaking. The timing of a proposed rule is unclear at this time, but CHA will keep members apprised of any new administrative process that is put forward.
Federal Court Halts Implementation of 340B Rebate Pilot Program
What’s happening: On Dec. 29, 2025, the U.S. District Court of Maine blocked implementation of the federal Department of Health and Human Services (HHS) 340B Rebate Model Pilot Program from going into effect nationwide on January 1, 2026, pending further orders from the court.
CHA Issues Summary of CY 2026 OPPS Final Rule
What’s happening: A detailed summary of the finalized provisions of the calendar year (CY) 2026 outpatient prospective payment system (OPPS) final rule is available for members.
CHA Urges CMS to Increase OPPS Payment Update, Rescind Harmful Proposals
What’s happening: On Sept. 15, CHA submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the calendar year 2026 outpatient prospective payment system (OPPS) proposed rule.
CHA Files Amicus Brief Opposing Drug Manufacturers’ Lawsuits Over 340B Rebate Models
What’s happening: CHA has filed an amicus (“friend of the court”) brief with 36 other state and regional hospital associations supporting the Health Resources and Services Administration (HRSA) against pharmaceutical manufacturers’ appeal of rulings related to 340B Drug Pricing Program rebate models.
Congress Shares Concerns About Proposed 340B Rebate Model with Health Secretary
What’s happening: A bipartisan group of U.S. representatives sent a letter to U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. outlining concerns about the proposed 340B Rebate Model Pilot Program.